{"pub": "marketwatch", "url": "https://marketwatch.com/articles/why-johnson-johnson-stock-can-weather-legal-awards-against-it-51570832221", "downloaded_at": "2019-10-12 00:31:34.875031+00:00", "title": "Why Johnson & Johnson Stock Can Weather Legal Awards Against It", "language": "en", "text": "It isn\u2019t likely that Johnson & Johnson will actually need to pay the $8 billion that a Pennsylvania jury lay at its feet in a personal injury case this past week. But the staggering number of zeros worried some investors, and the company lost $7.3 billion in market capitalization over the next two days.\n\nPersonal injury lawsuits are part of the game for big pharma companies, and Johnson & Johnson (ticker: JNJ) is the biggest. But the skirmishes are starting to look like a siege. The company lost a $572 million decision...", "description": "Investors may have overreacted to Johnson & Johnson\u2019s recent spate of multbillion-dollar losses in personal injury cases. J&J is big and aggressive, and can weather the legal awards, which may be less than the estimates.", "authors": ["Josh Nathan-Kazis"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DG508_JJfolo_OR_20191010114548.jpg", "published_at": "2019-10-11"}